Characterization of the specificities of human blood group H gene-specified alpha 1,2-L-fucosyltransferase toward sulfated/sialylated/fucosylated acceptors: Evidence for an inverse relationship between alpha 1,2-L-fucosylation of Gal and alpha 1,6-L-fucosylation of asparagine-linked GlcNAc

被引:21
作者
Chandrasekaran, EV
Jain, RK
Larsen, RD
Wlasichuk, K
Matta, KL
机构
[1] ROSWELL PK CANC INST,DEPT GYNECOL ONCOL,BUFFALO,NY 14263
[2] GLYCOMED INC,ALAMEDA,CA 94501
关键词
D O I
10.1021/bi952193m
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The assembly of complex structures bearing the H determinant was examined by characterizing the specificities of a cloned blood group H gene-specified alpha 1,2-L-fucosyltransferase (FT) toward a variety of sulfated, sialylated, or fucosylated Gal beta 1,3/4GlcNAc beta- or Gal beta 1,3GalNAc alpha-based acceptor structures. (a) As compared to the basic type 2, Gal beta 1,4GlcNAc beta- (K-m = 1.67 mM), the basic type 1 was 137% active (K-m = 0.83 mM). (b) On C-6 sulfation of Gal, type 1 became 142.1% active and type 2 became 223.0% active (K-m = 0.45 mM). (c) On C-6 sulfation of GlcNAc, type 2 showed 33.7% activity. (d) On C-3 or C-4 fucosylation of GlcNAc, both types 1 and 2 lost activity. (e) Type 1 showed 70.8% and 5.8% activity, respectively, on C-6 and C-4 O-methylation of GlcNAc. (f) Type 1 retained 18.8% activity on alpha 2,6-sialylation of GlcNAc. (g) Terminal type 1 or 2 of extended chain had lower activity. (h) With Gal in place of GlcNAc in type 1, the activity became 43.2%. (i) Compounds with terminal alpha 1,3-linked Gal were inactive. (j) Gal beta 1,3GalNAc alpha- (the T-hapten) was similar to 0.4-fold as active as Gal beta 1,4GlcNAc beta-. (k) C-6 sulfation of Gal on the T-hapten did not affect the acceptor activity. (1) C-6 sulfation of GalNAc decreased the activity to 70%, whereas on C-6 sulfation of both Gal and GalNAc the T-hapten lost the acceptor ability. (m) C-6 sialylation of GalNAc also led to inactivity. (n) beta 1,6 branching from GalNAc of the T-hapten by a GlcNAc residue or by units such as Gal beta 1,4GlcNAc-, Gal beta 1,4(Fuc alpha 1,3)GlcNAc-, or 3-sulfoGal beta 1,4GlcNAc- resulted in 111.9%, 282.8%, 48.3%, and 75.3% activities, respectively. (o) The enhancement of enzyme affinity by a sulfo group on C-6 of Gal was demonstrated by an increase (similar to 5-fold) in the K-m for Gal beta 1,4GlcNAc beta 1,6(Gal beta 1,3)GalNAc alpha-O-Bn in presence of 6-sulfoGal beta 1,- 4GlcNAc beta-O-Me (3.0 mM). (p) Among the two sites in Gal beta 1,4GlcNAc beta 1,6(Gal beta 1,3)GalNAc alpha-O-Bn, the enzyme had a higher affinity (>3-fold) for the Gal linked to GlcNAc. (q) With respect to Gal beta 1, 3GlcNAc beta-O-Bn (3.0 mM), fetuin triantennary asialo glycopeptide (2.4 mM), bovine IgG diantennary glycopeptide (2.8 mM), asialo Cowper's gland mucin (0.06 mM), and the acrylamide copolymers (0.125 mM each) containing Gal beta 1,3GlcNAc beta-, Gal beta 1,3(6-sulfo)GlcNAc beta-, Gal beta 1,3GalNAc alpha-, Gal beta 1,3Gal beta-, or Gal alpha 1,3Gal beta- units were 153.6%, 43.0%, 6.2%, 52.5%, 94.9%, 14.7%, 23.6%, and 15.6% active, respectively. (r) Fucosylation by alpha 1,2-L-FT of the galactosyl residue which occurs on the antennary structure of the bovine IgG glycopeptide was adversely affected by the presence of an alpha 1,6-L-fucosyl residue located on the distant glucosaminyl residue that is directly attached to the asparagine of the protein backbone. This became evident from the 4-fold activity of alpha 1,2-L-FT toward bovine IgG glycopeptide after similar to 50% removal of alpha 1,6-linked Fuc.
引用
收藏
页码:8914 / 8924
页数:11
相关论文
共 37 条
[1]   BIOSYNTHETIC PATHWAYS FOR THE LEB-GLYCOLIPIDS AND Y-GLYCOLIPIDS IN THE GASTRIC-CARCINOMA CELL-LINE KATO III AS ANALYZED BY A NOVEL ASSAY [J].
BLASZCZYKTHURIN, M ;
SARNESTO, A ;
THURIN, J ;
HINDSGAUL, O ;
KOPROWSKI, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 151 (01) :100-108
[2]   THE CARBOHYDRATE-COMPOSITION OF MUCIN IN COLONIC-CANCER [J].
BOLAND, CR ;
DESHMUKH, GD .
GASTROENTEROLOGY, 1990, 98 (05) :1170-1177
[3]   IMMUNOHISTOCHEMICAL LOCALIZATION OF Y-HAPTEN AND THE STRUCTURALLY RELATED H-TYPE-2 BLOOD-GROUP ANTIGEN ON LARGE-BOWEL TUMORS AND NORMAL ADULT TISSUES [J].
BROWN, A ;
ELLIS, IO ;
EMBLETON, MJ ;
BALDWIN, RW ;
TURNER, DR ;
HARDCASTLE, JD .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (06) :727-736
[4]  
CHANDRASEKARAN EV, 1992, J BIOL CHEM, V267, P23806
[5]   A BIOSYNTHETIC CONTROL ON STRUCTURES SERVING AS LIGANDS FOR SELECTINS - THE PRECURSOR STRUCTURES, 3-SIALYL/SULFO GAL-BETA-1,3/4GLCNAC-BETA-0-R, WHICH ARE HIGH-AFFINITY SUBSTRATES FOR ALPHA-1,3/4-L-FUCOSYL-TRANSFERASES, EXHIBIT THE PHENOMENON OF SUBSTRATE-INHIBITION [J].
CHANDRASEKARAN, EV ;
RHODES, JM ;
JAIN, RK ;
BERNACKI, RJ ;
MATTA, KL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (01) :78-89
[6]   LACTOSE AS AFFINITY FLUENT AND A SYNTHETIC SULFATED COPOLYMER AS INHIBITOR, IN CONJUNCTION WITH SYNTHETIC AND NATURAL ACCEPTORS, DIFFERENTIATE HUMAN-MILK LEWIS-TYPE AND PLASMA-TYPE ALPHA-L-FUCOSYLTRANSFERASES [J].
CHANDRASEKARAN, EV ;
RHODES, JM ;
JAIN, RK ;
MATTA, KL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (01) :350-358
[7]   SELECTIN LIGANDS AND TUMOR-ASSOCIATED CARBOHYDRATE STRUCTURES - SPECIFICITIES OF ALPHA-2,3-SIALYLTRANSFERASES IN THE ASSEMBLY OF 3'-SIALYL-6-SULFO/SIALYL LEWIS-A AND LEWIS-X, 3'-SIALYL-6'-SULFO LEWIS-X, AND 3'-SIALYL-6-SIALYL/SULFO BLOOD-GROUP T-HAPTEN [J].
CHANDRASEKARAN, EV ;
JAIN, RK ;
LARSEN, RD ;
WLASICHUK, K ;
MATTA, KL .
BIOCHEMISTRY, 1995, 34 (09) :2925-2936
[8]  
CHANDRASEKARAN EV, 1992, J BIOL CHEM, V267, P19929
[9]  
COOPER HS, 1991, AM J PATHOL, V138, P103
[10]  
COOPER HS, 1978, AM J CLIN PATHOL, V69, P594